Frontiers in Virology | Virus and Host Immunity

Original Research

Published on 26 Jun 2026

Mass-standardised antibody concentration and affinity immunity endotypes to the spike protein of SARS-CoV-2 variants in a high-exposure cohort

in Virus and Host Immunity

Philip H. James-Pemberton
Shivali Kohli
Aaron C. Westlake
Alex Antill
Rouslan V. Olkhov
Andrew M. Shaw

Frontiers in Virology

doi 10.3389/fviro.2026.1837217

702 views

Correction

Published on 22 May 2026

Correction: Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic Virus

in Virus and Host Immunity

Ernesto de Bernardis
Fabio Lugoboni
Lina Busà
Giulio Petronio Petronio
Roberto Di Marco

Frontiers in Virology

doi 10.3389/fviro.2026.1840666

682 views

Systematic Review

Published on 15 May 2026

Immune evasion of human metapneumovirus during respiratory tract infections: systematic review

in Virus and Host Immunity

Yuling Han
Lishu Zheng
Chao Wang
Fang Huang
Cheng Gong
Xuejiao Guan

Frontiers in Virology

doi 10.3389/fviro.2026.1791383

1,309 views

Brief Research Report

Published on 27 Apr 2026

Increasing CD4/CD8 ratio confirmed after two years of long-acting cabotegravir and rilpivirine in the SCohoLART study

in Virus and Host Immunity

Gabriele Loi
Nicolò Capra
Riccardo Lolatto
Marcella Negri
Gaia Catalano
Flavia Passini
Nicolò Moschetta
Claudia Benelli
Silvia Nozza
Antonella Castagna

Frontiers in Virology

doi 10.3389/fviro.2026.1819287

1,318 views

Perspective

Published on 27 Mar 2026

Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic Virus

in Virus and Host Immunity

Ernesto de Bernardis
Fabio Lugoboni
Lina Busà
Giulio Petronio Petronio
Roberto Di Marco

Frontiers in Virology

doi 10.3389/fviro.2026.1801380

1,529 views

Review

Published on 19 Jan 2026

Bridging the gap: addressing real-life challenges to the implementation of DTG/3TC in treatment-naive people living with HIV

in Virus and Host Immunity

Andrea Giacomelli
Gianmaria Baldin
Valeria Bono
Arturo Ciccullo
Maria Mazzitelli
Mariacristina Poliseno
Marco Ridolfi
Federica Sozio
Elisabetta Teti
Giulia Marchetti

Frontiers in Virology

doi 10.3389/fviro.2025.1749039

1,924 views

Clinical Trial

Published on 31 Oct 2025

Human Cytomegalovirus infection in the era of vaccine development: case series of immunocompromised patients

in Virus and Host Immunity

Nadia Marascio
Grazia Pavia
Chiara Mazzei
Marta Pantanella
Emanuele Giorgio
Michele Manno
Simona Gigliotti
Giorgio Settimo Barreca
Cinzia Peronace
Giovanni Matera

Frontiers in Virology

doi 10.3389/fviro.2025.1698340

3,603 views
1 citation

Original Research

Published on 02 Jun 2025

IL-27 effects on HIVGag-specific CD4 and CD8 T cell function

in Virus and Host Immunity

Maryam Abdussamad
Grace Katz
Jie Cheng
Chinmayee Mehta
Fernando Andres-Martin
Danial Mahmood
Princy Kumar
Marta Catalfamo

Frontiers in Virology

doi 10.3389/fviro.2025.1600802

3,625 views
2 citations

Editorial

Published on 22 Jan 2025

Editorial: Innate and adaptive immune responses to viral infection

in Virus and Host Immunity

Stefania Varchetta
Emanuela Marcenaro

Frontiers in Virology

doi 10.3389/fviro.2025.1554611

4,989 views
1 citation

Case Report

Published on 07 Jan 2025

Case report: Kinetics of viral load, immunoglobulins, and cytokines in a fatal case of Crimean-Congo hemorrhagic fever virus

in Virus and Host Immunity

Moufid Mhamadi
Ousseynou Sene
Arfang Diamanka
Moundhir Mhamadi
Marie Pedapa Mendy
Andy Mahine Diouf
Mignane Ndiaye
Mamadou Aliou Barry
Samba Niang Sagne
Mahfouz Cissé Traoré

Frontiers in Virology

doi 10.3389/fviro.2024.1498672

2,463 views
1 citation

Original Research

Published on 08 Nov 2024

Seroprevalence of anti-SARS-CoV-2 IgM and IgG and COVID-19 vaccine uptake in healthy volunteers in Nairobi, Kenya: a cross-sectional study

in Virus and Host Immunity

Agnes Muhonja Otindo
Eric M. Ndombi
Martin Theuri
Margaret Muturi
Peris Thamaini
James Ogutu
Lister Onsongo
June K. Madete
Victor Ofula
Samuel Gitau

Frontiers in Virology

doi 10.3389/fviro.2024.1479645

2,903 views
1 citation

Review

Published on 28 Oct 2024

Human cellular restriction factors that target SARS-CoV-2 replication

in Virus and Host Immunity

Amukelani Marivate
Shani Bekker
Muhammad Qasim Fish
Salerwe Mosebi

Frontiers in Virology

doi 10.3389/fviro.2024.1462283

5,442 views

Original Research

Published on 18 Oct 2024

Klebsiella pneumoniae co-infection leads to fatal pneumonia in SARS-CoV-2-infected mice

in Virus and Host Immunity

Crystal Villalva
Girish Patil
Sai Sankara Narayanan
Roshan Ghimire
Debarati Chanda
Nishantha Samarakoon
Timothy Snider
Akhilesh Ramachandran
Rudragouda Channappanavar
Sunil More

Frontiers in Virology

doi 10.3389/fviro.2024.1426728

4,071 views
1 citation

Original Research

Published on 06 Aug 2024

Severe acute respiratory syndrome coronavirus-2 seroprevalence in non-vaccinated people living with HIV in Uganda during 2022

in Virus and Host Immunity

Provia Ainembabazi
Letisha Najjemba
Joseph Musaazi
Mario Hönemann
Barbara Castelnuovo
Amrei von Braun

Frontiers in Virology

doi 10.3389/fviro.2024.1429785

2,816 views

Mini Review

Published on 01 May 2024

Wielding a double-edged sword: viruses exploit host DNA repair systems to facilitate replication while bypassing immune activation

in Virus and Host Immunity

Nicholas Saladino
Daniel J. Salamango

Frontiers in Virology

doi 10.3389/fviro.2024.1410258

6,588 views
4 citations

Mini Review

Published on 06 Mar 2024

DNA methylation in long COVID

in Virus and Host Immunity

Yangfan Xiao
Sten H. Vermund

Frontiers in Virology

doi 10.3389/fviro.2024.1371683

8,611 views
8 citations

Original Research

Published on 24 Jan 2024

APOBEC3D excludes APOBEC3F from HIV-1 virions by competitive binding of RNA

in Virus and Host Immunity

Shreoshri Bhattacharjee
Amit Gaba
Linda Chelico

Frontiers in Virology

doi 10.3389/fviro.2024.1343037

3,254 views

Review

Published on 18 Dec 2023

APOBEC3 family proteins as drivers of virus evolution

in Virus and Host Immunity

Michael Jonathan
Terumasa Ikeda

Frontiers in Virology

doi 10.3389/fviro.2023.1332010

7,363 views
18 citations

Review

Published on 13 Nov 2023

Beyond survival: unraveling the dynamics of Ebola virus resurgence in Sub-Saharan Africa and the remarkable journey of survivors

in Virus and Host Immunity

Eric Asare Fenteng
Paul Poku Sampene Ossei
William Gilbert Ayibor
Tracy Narh-Bedu

Frontiers in Virology

doi 10.3389/fviro.2023.1227314

9,785 views
2 citations

Original Research

Published on 27 Jun 2023

Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity

in Virus and Host Immunity

Ana C. Maretti-Mira
Matthew P. Salomon
Angela M. Hsu
Chikako Matsuba
Lucy Golden-Mason

Frontiers in Virology

doi 10.3389/fviro.2023.1198361

13,690 views
4 citations

Original Research

Published on 02 Jun 2023

Antiviral treatment with valacyclovir reduces virus shedding in saliva of Antarctic expeditioners

in Virus and Host Immunity

Satish K. Mehta
Douglass M. Diak
Bridgette V. Rooney
Stephanie S. Krieger
Mayra Nelman-Gonzalez
James P. Locke
Maria A. Nagel
Millennia Young
Brian E. Crucian

Frontiers in Virology

doi 10.3389/fviro.2023.1157659

17,322 views
6 citations

Review

Published on 06 Mar 2023

Malignancy and viral infections in Sub-Saharan Africa: A review

in Virus and Host Immunity

Mahamadou Diakite
Kathryn Shaw-Saliba
Chuen-Yen Lau

Frontiers in Virology

doi 10.3389/fviro.2023.1103737

62,556 views
33 citations

Original Research

Published on 03 Mar 2023

Epitope mapping of SARS-CoV-2 spike protein differentiates the antibody binding activity in vaccinated and infected individuals

in Virus and Host Immunity

Nathaniel Felbinger
David Trudil
Lawrence Loomis
Richard Ascione
Gregory Siragusa
Seiji Haba
Shruti Rastogi
Aidan Mucci
Mark Claycomb
Sebastian Snowberger

Frontiers in Virology

doi 10.3389/fviro.2023.988109

5,572 views
4 citations

Original Research

Published on 01 Mar 2023

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses

in Virus and Host Immunity

Pradeepa Pushparaj
Andrea Nicoletto
Xaquin Castro Dopico
Daniel J. Sheward
Sungyong Kim
Simon Ekström
Ben Murrell
Martin Corcoran
Gunilla B. Karlsson Hedestam

Frontiers in Virology

doi 10.3389/fviro.2023.1128253

5,831 views
13 citations

47 articles

articles

Mass-standardised antibody concentration and affinity immunity endotypes to the spike protein of SARS-CoV-2 variants in a high-exposure cohort

Correction: Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic Virus

Immune evasion of human metapneumovirus during respiratory tract infections: systematic review

Increasing CD4/CD8 ratio confirmed after two years of long-acting cabotegravir and rilpivirine in the SCohoLART study

Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic Virus

Bridging the gap: addressing real-life challenges to the implementation of DTG/3TC in treatment-naive people living with HIV

Human Cytomegalovirus infection in the era of vaccine development: case series of immunocompromised patients

IL-27 effects on HIVGag-specific CD4 and CD8 T cell function

Editorial: Innate and adaptive immune responses to viral infection

Case report: Kinetics of viral load, immunoglobulins, and cytokines in a fatal case of Crimean-Congo hemorrhagic fever virus

Seroprevalence of anti-SARS-CoV-2 IgM and IgG and COVID-19 vaccine uptake in healthy volunteers in Nairobi, Kenya: a cross-sectional study

Human cellular restriction factors that target SARS-CoV-2 replication

Klebsiella pneumoniae co-infection leads to fatal pneumonia in SARS-CoV-2-infected mice

Severe acute respiratory syndrome coronavirus-2 seroprevalence in non-vaccinated people living with HIV in Uganda during 2022

Wielding a double-edged sword: viruses exploit host DNA repair systems to facilitate replication while bypassing immune activation

DNA methylation in long COVID

APOBEC3D excludes APOBEC3F from HIV-1 virions by competitive binding of RNA

APOBEC3 family proteins as drivers of virus evolution

Beyond survival: unraveling the dynamics of Ebola virus resurgence in Sub-Saharan Africa and the remarkable journey of survivors

Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity

Antiviral treatment with valacyclovir reduces virus shedding in saliva of Antarctic expeditioners

Malignancy and viral infections in Sub-Saharan Africa: A review

Epitope mapping of SARS-CoV-2 spike protein differentiates the antibody binding activity in vaccinated and infected individuals

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses